References
Fujimoto K, Shihara S, Yanagisawe H, Ide J, Nakayama E, Nakao H, Sugawara S, Iwata M Studies on orally active cephalosporin esters. Journal of Antibiotics 1987, 40: 370–384.
Utsui Y, Inove M, Mitsuhashi S In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1987, 31: 1085–1092.
Chin NX, Neu HC In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746. Antimicrobial Agents and Chemotherapy 1988, 32: 671–677.
Jones RN, Barry AL Antimicrobial activity and disc diffusion susceptibility testing of U-76, 253A (R-3746), the active metabolite of the new cephalosporin ester, U-76, 252 (CS-807). Antimicrobial Agents and Chemotherapy 1988, 32: 443–449.
Knapp CC, Sierra-Madero J, Washington JA Antibacterial activities of cefpodoxime, cefixime and ceftriaxone. Antimicrobial Agents and Chemotherapy 1988, 32: 1896–1898.
Fass RJ, Helsel VL In vitro activity of U-76, 252 (CS-807), a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1988, 32: 1082–1085.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schumacher-Perdreau, F., Jansen, B. & Peters, G. In vitro activity of cefpodoxime against staphylococci in comparison to other cephalosporins. Eur. J. Clin. Microbiol. Infect. Dis. 10, 585–588 (1991). https://doi.org/10.1007/BF01967279
Issue Date:
DOI: https://doi.org/10.1007/BF01967279